| Organism name | Liriodendron tulipifera | 
|---|---|
| Genus | Liriodendron | 
| Family | Magnoliaceae | 
| Kingdom | Plantae | 
| Linked NCBI taxonomy name | Liriodendron tulipifera | 
|---|---|
| Linked NCBI taxonomy ID | 3415 | 
| Linked level | species | 
| Family in NCBI taxonomy | Magnoliaceae | 
|---|---|
| ID | 3401 | 
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae | 
|---|---|
| ID | 33090 | 
| Plant class | Magnoliophyta | 
|---|---|
| ID | 3398 | 
| Species | Activity | 
|---|---|
| Liriodendron tulipifera L. | Analgesic | 
| Liriodendron tulipifera L. | Antibacterial | 
| Liriodendron tulipifera L. | Antiinflammatory | 
| Liriodendron tulipifera L. | Antipyretic | 
| Liriodendron tulipifera L. | Antiseptic | 
| Liriodendron tulipifera L. | Aphrodisiac | 
| Liriodendron tulipifera L. | Bitter | 
| Liriodendron tulipifera L. | Candidicide | 
| Liriodendron tulipifera L. | Cardiotonic | 
| Liriodendron tulipifera L. | Depurative | 
| Liriodendron tulipifera L. | Diaphoretic | 
| Liriodendron tulipifera L. | Digitalic | 
| Liriodendron tulipifera L. | Diuretic | 
| Liriodendron tulipifera L. | Fungicide | 
| Liriodendron tulipifera L. | Positive Inotropic | 
| Liriodendron tulipifera L. | Stimulant | 
| Liriodendron tulipifera L. | Tonic | 
| Liriodendron tulipifera L. | Vermifuge | 
| KNApSAcK ID | name | ChEMBL link | CTD link | # of proteins in ChEMBL interaction / related OMIM / related KEGG DISEASE | # of genes in CTD interaction / related diseases | KCF-S cluster | phytochemical cluster | figure | 
|---|---|---|---|---|---|---|---|---|
| C00028475   | Lirioferine | No. 20 | No. 4 |   | ||||
| C00025675   | Lauroscholtzine / 2-O-Methylboldine / N-Methyllaurotetanine / (+)-N-Methyllaurotetanine | CHEMBL464099 | 1 / 1 / 0 | No. 20 | No. 4 |   | ||
| C00001861   | Glaucine / S-(+)-Glaucine / O,O-Dimethylisoboldine | CHEMBL36536 CHEMBL228082 | 14 / 8 / 6 | No. 20 | No. 4 |   | ||
| C00025931   | Liriotulipiferine | CHEMBL1996399 | No. 20 | No. 4 |   | |||
| C00001825   | Caaverine / (-)-Caaverine | No. 20 | No. 4 |   | ||||
| C00000659   | Medioresinol / (+)-Medioresinol | CHEMBL376507 CHEMBL513023 | 2 / 1 / 1 | No. 38 | No. 21 |   | ||
| C00000642   | (+)-Yangambin | CHEMBL510536 CHEMBL454592 CHEMBL1412125 | 4 / 2 / 0 | No. 38 | No. 21 |   | ||
| C00007190   | (+)-Pinoresinol | CHEMBL267963 CHEMBL487611 CHEMBL460862 | C103298 | 7 / 5 / 6 | No. 38 | No. 21 |   | |
| C00002631   | (+)-Lirioresinol B / (+)-Syringaresinol | CHEMBL361362 CHEMBL402653 | C042192 | 1 / 0 / 0 | No. 38 | No. 21 |   | |
| C00000640   | (+)-Eudesmin | CHEMBL519099 CHEMBL512865 CHEMBL523743 CHEMBL464352 CHEMBL1726879 | C105875 | 2 / 0 / 0 | No. 38 | No. 21 |   | |
| C00001878   | Liriodenine / Oxoushinsunine / Spermatheridine | CHEMBL37736 | C026980 | 5 / 3 / 1 | No. 74 |   | ||
| C00012975   | alpha-Liriodenolide / [3aR-(3aalpha,4beta,5abeta,6beta,9aalpha,9bbeta)]-4-(acetyloxy)-3a,4,5,5a,6,7,9a,9b-octahydro-6-hydroxy-5a,9-dimethyl-3-methylenenaphtho[1,2-b]furan-2(3H)-one | No. 157 | No. 38 |   | ||||
| C00012978   | gamma-Liriodenolide / [3aR-(3aalpha,4beta,5abeta,6beta,9bbeta)]-4-(acetyloxy)-3a,4,5,5a,6,7,8,9b-Octahydro-6-hydroxy-5a,9-dimethyl-3-methylenenaphtho[1,2-b]furan-2(3H)-one | No. 157 | No. 38 |   | ||||
| C00012982   | beta-Liriodenolide / [3aR-(3aalpha,4beta,5abeta,6beta,9aalpha,9bbeta)]-4-(Acetyloxy)decahydro-6-hydroxy-5a-methyl-3,9-bis(methylene)-naphtho[1,2-b]furan-2(3H)-one | No. 157 | No. 38 |   | ||||
| C00020472   | Michefuscalide / beta-Cyclolipiferolide | C059287 | No. 157 | No. 38 |   | |||
| C00003378   | Tulipinolide | CHEMBL520114 | No. 249 | No. 38 |   | |||
| C00012329   | Tulirinol | No. 249 | No. 38 |   | ||||
| C00003379   | epi-Tulipinolide | CHEMBL520114 | No. 249 | No. 38 |   | |||
| C00001164   | Myoinositol / myo-Inositol | CHEMBL278373 CHEMBL468154 CHEMBL1222251 CHEMBL1231671 CHEMBL1950780 | 8 / 17 / 18 | No. 795 |   | |||
| C00003347   | 1-Peroxyferolide | CHEMBL518136 | No. 843 | No. 38 |   | |||
| C00003319   | Lipiferolide | No. 843 | No. 38 |   | ||||
| C00002498   | Scoparone / 6,7-Dimethoxycoumarin / Aesculetin dimethyl ether | CHEMBL325864 | C018145 | 4 / 2 / 2 | 6 / 0 | No. 864 | No. 25 |   | 
| C00003380   | epi-Tulipinolide diepoxide | No. 1056 | No. 38 |   | ||||
| C00012037   | Elemanolide / Epitulipdienolide | No. 1132 |   | 
| accession | description | class description | KNApSAcK metabolite in interactions | # of diseases (OMIM / KEGG) | 
|---|---|---|---|---|
| O75496 | Geminin | Unclassified protein | C00000642 C00001164 C00001861 | 0 / 0 | 
| Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00000642 C00001861 C00007190 | 0 / 0 | 
| Q9UNA4 | DNA polymerase iota | Enzyme | C00001164 C00001861 | 0 / 0 | 
| Q9UBT6 | DNA polymerase kappa | Enzyme | C00000640 C00000642 | 0 / 0 | 
| Q14761 | Protein tyrosine phosphatase receptor type C-associated protein | Enzyme | C00001861 C00001878 | 0 / 0 | 
| Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00000640 | 0 / 0 | 
| Q96LD8 | Sentrin-specific protease 8 | Enzyme | C00001861 | 0 / 0 | 
| P42574 | Caspase-3 | C14 | C00001861 | 0 / 0 | 
| P05091 | Aldehyde dehydrogenase, mitochondrial | Oxidoreductase | C00002498 | 1 / 1 | 
| P16278 | Beta-galactosidase | Enzyme | C00001164 | 4 / 6 | 
| P30926 | Neuronal acetylcholine receptor subunit beta-4 | CHRN beta | C00001878 | 0 / 0 | 
| P32297 | Neuronal acetylcholine receptor subunit alpha-3 | CHRN alpha | C00001878 | 1 / 0 | 
| P17787 | Neuronal acetylcholine receptor subunit beta-2 | CHRN beta | C00001878 | 1 / 1 | 
| P43681 | Neuronal acetylcholine receptor subunit alpha-4 | CHRN alpha | C00001878 | 1 / 1 | 
| Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00001861 | 1 / 0 | 
| Q9BQF6 | Sentrin-specific protease 7 | Enzyme | C00001861 | 0 / 0 | 
| Q9GZR1 | Sentrin-specific protease 6 | Enzyme | C00001861 | 0 / 0 | 
| P11387 | DNA topoisomerase 1 | Isomerase | C00002631 | 0 / 0 | 
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000659 | 1 / 0 | 
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00001861 | 0 / 0 | 
| P02545 | Prelamin-A/C | Unclassified protein | C00001164 | 11 / 10 | 
| P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00000642 | 2 / 0 | 
| Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00007190 | 0 / 0 | 
| P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00007190 | 5 / 3 | 
| P06280 | Alpha-galactosidase A | Enzyme | C00001164 | 1 / 1 | 
| P56817 | Beta-secretase 1 | A1A | C00002498 | 0 / 0 | 
| Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00001861 | 3 / 3 | 
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00007190 | 0 / 3 | 
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000659 | 0 / 1 | 
| P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00007190 | 0 / 0 | 
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00001861 | 4 / 3 | 
| O43451 | Maltase-glucoamylase, intestinal | Hydrolase | C00001164 | 0 / 0 | 
| P08908 | 5-hydroxytryptamine receptor 1A | Serotonin receptor | C00025675 | 1 / 0 | 
| Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | C00007190 | 0 / 0 | 
| P10323 | Acrosin | S1A | C00001164 | 0 / 0 | 
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00001861 | 0 / 0 | 
| P27338 | Amine oxidase [flavin-containing] B | Oxidoreductase | C00002498 | 0 / 0 | 
| P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00002498 | 1 / 1 | 
| Q9H0H5 | Rac GTPase-activating protein 1 | Unclassified protein | C00007190 | 0 / 0 | 
| P43351 | DNA repair protein RAD52 homolog | Unclassified protein | C00001861 | 0 / 0 | 
| Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00001164 | 1 / 1 | 
| gene | gene name | gene description | KNApSAcK metabolite in interactions | 
|---|---|---|---|
| 6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 | C00002498 | 
| 3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 | C00002498 | 
| 4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | C00002498 | 
| 4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | C00002498 | 
| 5966 | REL, C-Rel | v-rel avian reticuloendotheliosis viral oncogene homolog | C00002498 | 
| 5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A | C00002498 | 
| OMIM | preferred title | UniProt | 
|---|---|---|
| #300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency | Q99714 | 
| #610251 | Alcohol sensitivity, acute | P05091 | 
| #612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 | Q13148 | 
| %606641 | Body mass index; bmi | P37231 | 
| #300615 | Brunner syndrome | P21397 | 
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a | P02545 | 
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism | P02545 | 
| #609338 | Carotid intimal medial thickness 1 | P37231 | 
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 | P02545 | 
| #114500 | Colorectal cancer; crc | P84022 | 
| #608902 | Drug metabolism, poor, cyp2d6-related | P10635 | 
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 | P02545 | 
| #600513 | Epilepsy, nocturnal frontal lobe, 1; enfl1 | P43681 | 
| #605375 | Epilepsy, nocturnal frontal lobe, 3; enfl3 | P17787 | 
| #301500 | Fabry disease | P06280 | 
| #600274 | Frontotemporal dementia; ftd | P10636 | 
| #137800 | Glioma susceptibility 1; glm1 | P37231 | 
| #230500 | Gm1-gangliosidosis, type i | P16278 | 
| #230600 | Gm1-gangliosidosis, type ii | P16278 | 
| #230650 | Gm1-gangliosidosis, type iii | P16278 | 
| #610140 | Heart-hand syndrome, slovenian type | P02545 | 
| #176670 | Hutchinson-gilford progeria syndrome; hgps | P02545 | 
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 | P02545 | 
| #604367 | Lipodystrophy, familial partial, type 3; fpld3 | P37231 | 
| #613795 | Loeys-dietz syndrome, type 3; lds3 | P84022 | 
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada | P02545 | 
| #300705 | Mental retardation, x-linked 17; mrx17 | Q99714 | 
| #300220 | Mental retardation, x-linked, syndromic 10; mrxs10 | Q99714 | 
| #253010 | Mucopolysaccharidosis type ivb | P16278 | 
| #613205 | Muscular dystrophy, congenital, lmna-related | P02545 | 
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b | P02545 | 
| #160900 | Myotonic dystrophy 1; dm1 | Q9NR56 | 
| #601665 | Obesity | P37231 | 
| #260540 | Parkinson-dementia syndrome | P10636 | 
| #614674 | Periodic fever, menstrual cycle-dependent | P08908 | 
| #172700 | Pick disease of brain | P10636 | 
| #275210 | Restrictive dermopathy, lethal | P02545 | 
| #612052 | Smoking as a quantitative trait locus 3; sqtl3 | P32297 | 
| #601104 | Supranuclear palsy, progressive, 1; psnp1 | P10636 | 
| KEGG | name | UniProt | 
|---|---|---|
| H00264 | Charcot-Marie-Tooth disease (CMT) | P02545
                            (related) | 
| H00294 | Dilated cardiomyopathy (DCM) | P02545
                            (related) | 
| H00420 | Familial partial lipodystrophy (FPL) | P02545
                            (related) P37231 (related) | 
| H00563 | Emery-Dreifuss muscular dystrophy | P02545
                            (related) | 
| H00590 | Congenital muscular dystrophies (CMD/MDC) | P02545
                            (related) | 
| H00593 | Limb-girdle muscular dystrophy (LGMD) | P02545
                            (related) | 
| H00601 | Hutchinson-Gilford progeria syndrome | P02545
                            (related) | 
| H00663 | Restrictive dermopathy | P02545
                            (related) | 
| H00665 | Mandibuloacral dysplasia | P02545
                            (related) | 
| H01216 | Left ventricular noncompaction (LVNC) | P02545
                            (related) | 
| H01071 | Acute alcohol sensitivity | P05091
                            (related) | 
| H00125 | Fabry disease | P06280
                            (related) | 
| H00036 | Osteosarcoma | P08684
                            (marker) | 
| H00058 | Amyotrophic lateral sclerosis (ALS) | P10636
                            (related) Q13148 (related) | 
| H00077 | Progressive supranuclear palsy (PSP) | P10636
                            (related) | 
| H00078 | Frontotemporal lobar degeneration (FTLD) | P10636
                            (related) | 
| H00123 | Mucopolysaccharidosis type IV (MPS4) | P16278
                            (related) | 
| H00276 | Galactosialidosis | P16278
                            (related) | 
| H00281 | GM1 gangliosidosis | P16278
                            (related) | 
| H00421 | Mucopolysaccharidosis (MPS) | P16278
                            (related) | 
| H00422 | Glycoproteinoses | P16278
                            (related) | 
| H00426 | Defects in the degradation of ganglioside | P16278
                            (related) | 
| H00807 | Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) | P17787
                            (related) P43681 (related) | 
| H00548 | Brunner syndrome | P21397
                            (related) | 
| H00017 | Esophageal cancer | P35354
                            (related) | 
| H00025 | Penile cancer | P35354
                            (related) | 
| H00046 | Cholangiocarcinoma | P35354
                            (related) | 
| H00032 | Thyroid cancer | P37231
                            (related) | 
| H00409 | Type II diabetes mellitus | P37231
                            (related) | 
| H00480 | Non-syndromic X-linked mental retardation | Q99714
                            (related) | 
| H00658 | Syndromic X-linked mental retardation | Q99714
                            (related) | 
| H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency | Q99714
                            (related) |